• Allogene Therapeutics, Inc. (NASDAQ:ALLO) Receives Consensus Recommendation of "Moderate Buy" from Analysts

    来源: Buzz FX / 15 3月 2025 09:52:17   America/New_York


    Allogene Therapeutics, Inc. (NASDAQ:ALLO) Receives Consensus Recommendation of "Moderate Buy" from Analysts Written by MarketBeat March 15, 2025 Share Link copied to clipboard. Remove Ads Shares of Allogene Therapeutics, Inc.
    Read more...
分享